These results are consistent with previous findings which highlight the therapeutic relevance of PDE4 modulation in mood-related disorders and warrant future investigations in translatable models of depression (Wang et al., 2024; Li et al., 2009). This evidence concerns the gene PDE4A and depressive symptom measurement.